Impact of the APOBEC3A/B deletion polymorphism on risk of ovarian cancer.

Gansmo LB, Sofiyeva N, Bjørnslett M, Romundstad P, Hveem K, Vatten L, Dørum A, Lønning PE, Knappskog S

Open source

DOI
10.1038/s41598-021-02820-z
Published
2021 Dec 6
Container
Scientific reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41598-021-02820-z,
  title = {Impact of the APOBEC3A/B deletion polymorphism on risk of ovarian cancer.},
  author = {Gansmo LB and Sofiyeva N and Bjørnslett M and Romundstad P and Hveem K and Vatten L and Dørum A and Lønning PE and Knappskog S},
  year = {2021},
  journal = {Scientific reports},
  doi = {10.1038/s41598-021-02820-z},
  url = {https://doi.org/10.1038/s41598-021-02820-z}
}

RIS

TY  - JOUR
TI  - Impact of the APOBEC3A/B deletion polymorphism on risk of ovarian cancer.
AU  - Gansmo LB
AU  - Sofiyeva N
AU  - Bjørnslett M
AU  - Romundstad P
AU  - Hveem K
AU  - Vatten L
AU  - Dørum A
AU  - Lønning PE
AU  - Knappskog S
PY  - 2021
JO  - Scientific reports
DO  - 10.1038/s41598-021-02820-z
UR  - https://doi.org/10.1038/s41598-021-02820-z
ER  - 

APA

LB, G., N, S., M, B., P, R., K, H., L, V., A, D., PE, L., & S, K. (2021). Impact of the APOBEC3A/B deletion polymorphism on risk of ovarian cancer.. Scientific reports. https://doi.org/10.1038/s41598-021-02820-z

Source records